Table 2.
Healthy n = 20 | HH n = 53 | p-value | ||
---|---|---|---|---|
Phospholipids | ||||
PC | Saturated | 996.2 ± 369.3 | 750.6 ± 30.6 | < 0.0008a |
MUFA | 2327.0 ± 866.7 | 2401.8 ± 976.2 | 0.75a | |
PUFA | 6163.9 ± 2104.8 | 8001.3 ± 2334.6 | 0.003a | |
Alkyl | 521.6 ± 169.7 | 619.3 ± 203.1 | 0.045a | |
Total | 10,008.8 ± 3154.7 | 11,773.0 ± 3339.3 | 0.04a | |
LPC | Saturated | 51.5 ± 11.3 | 56.9 ± 14.6 | 0.10a |
MUFA | 12.5 ± 3.4 | 10.5 ± 2.7 | 0.02a | |
PUFA | 19.6 ± 4.2 | 16.2 ± 4.2 | 0.004a | |
Total | 83.7 ± 17.6 | 83.6 ± 19.7 | 0.98a | |
PI | MUFA | 14.4 ± 6.5 | 19.7 ± 10.0 | 0.01a |
PUFA | 137.4 ± 50.1 | 165.0 ± 61.0 | 0.06a | |
Total | 152.1 ± 55.7 | 184.7 ± 69.1 | 0.04a | |
PS | MUFA | 0.4 (2.6) | 0.0 (4.0) | 0.71b |
PUFA | 17.7 (17.9) | 24.6 (52.0) | 0.15b | |
Total | 18.4 (18.3) | 26.5 (59.5) | 0.18b | |
PE | MUFA | 75.2 (55.4) | 91.9 (329.7) | 0.05b |
PUFA | 198.6 (103.5) | 289.2 (257.0) | 0.005b | |
Total | 276.4 (123.2) | 407.8 (573.2) | 0.008b | |
LPE | Saturated | 1.2 (0.9) | 1.3 (0.8) | 0.87b |
MUFA | 0.5 (0.4) | 0.5 (0.9) | 0.95b | |
PUFA | 1.6 (0.8) | 2.3 (3.0) | 0.045b | |
Total | 3.6 (1.7) | 4.5 (4.8) | 0.10b | |
Sphingolipids | ||||
SM | Saturated | 711.3 ± 271.3 | 876.1 ± 279.5 | 0.03a |
MUFA | 2168.3 ± 1339.6 | 2879.7 ± 1173.2 | 0.045a | |
PUFA | 1537.9 ± 517.6 | 1728.4 ± 380.7 | 0.15a | |
Alkyl | 344.3 ± 256.5 | 465.4 ± 236.7 | 0.08a | |
Total | 4761.8 ± 2104.7 | 5949.6 ± 1743.3 | 0.03a | |
Ratio PC/PE | 34.7 | 22.2 |
HH hereditary hemochromatosis; IQR interquartile range; LPC lysophosphatidylcholine; LPE lysophosphatidylethanoletamine; MUFA monounsaturated fatty acid; PC phosphatidylcholine; PE phosphatidylethanolamine; PS phosphatidylserine; PUFA polyunsaturated fatty acid; SD standard deviation; SM sphingomyelin;